Latest news with #MDI
Business Wire
27-05-2025
- Health
- Business Wire
AirStrip® Introduces Alarm Management: A Game-Changing FDA Approved Integrated Platform Transforming Clinical Alarm Management of Vital Signs
SAN ANTONIO, Texas--(BUSINESS WIRE)-- AirStrip, a leader in vendor-agnostic clinical surveillance and decision support technologies, today announced the launch of AirStrip Alarm Management, an advanced integrated platform that modernizes how hospitals manage clinical alarms. This state-of-the-art, FDA approved solution routes critical alerts directly to clinicians' mobile devices, supported by waveform vital sign data, helping care teams respond faster and reduce alarm fatigue across care settings. Built to integrate seamlessly with existing systems, AirStrip Alarm Management supports a unified, vendor-neutral approach to alarm workflows. The MDI library enables hospitals to access data from disparate devices and systems, enhancing visibility and decision-making. Dr. Patrick Soon-Shiong, Chairman of AirStrip's Board of Directors, said, "This FDA approved platform is a meaningful advancement for healthcare systems. It simplifies alarm management, eases clinician workload, and contributes to a safer, more sustainable care environment especially for high risk, high cost patient care." With support from AirStrip, hospitals can custom-select configurations for alert escalations and notifications. This platform integrates with staff assignment solutions to avoid over-alerting while supporting unit-specific overrides, delivering clinically actionable alerts. Our centralized dashboard allows end users to dispatch alerts, document significant arrhythmias to the EHR, and track alarms in near-real time, offering automated audit trails for workflow transparency. Clinicians receive alerts enriched with contextual information and waveforms, allowing them to act immediately or escalate when necessary. The Alert Tracker feature gives hospital leaders insight into alarm activity across the system with near real-time updates and detailed logs. Dr. Haris Naseem, AirStrip's CEO and a practicing cardiac electrophysiologist, noted, "As someone who experiences alarm fatigue firsthand, I see the immediate clinical value of this solution. It brings clarity to urgent situations and helps us deliver faster, safer care." Since 2015, AirStrip has delivered innovative clinical surveillance solutions to hospitals nationwide. Following its acquisition of DECISIO® Health, the company has expanded its portfolio to include robust clinical decision support and visualization tools. The launch of AirStrip Alarm Management marks the next step in its mission to improve patient care, enhance clinical workflows, and support hospital staff at every level. AirStrip® is a leader in clinical surveillance, decision support, and alarm management solutions. Trusted by more than 675 hospitals and health systems across the United States, FDA approved software by AirStrip empowers clinicians to deliver timely, data-driven care with actionable insights at the point of care. Learn more at
Business Wire
21-05-2025
- Business
- Business Wire
ComEd Celebrates Rockford's First Graduating Class of New Market Development Initiative
BUSINESS WIRE)-- ComEd today graduated nearly a dozen participants of its first Skilled Cohort in Rockford; part of its Market Development Initiative (MDI) that provides resources and training to help create a diverse, local workforce that is qualified to take on roles in the growing energy efficiency industry. Over the course of five weeks, entrepreneurs completed training to become certified in the latest building standards and receive relevant knowledge to help advance their careers in energy efficiency, HVAC, or weatherization. 'To help support the communities we're privileged to serve, ComEd has made increasing training and contracting opportunities a top priority,' said Gil Quiniones, ComEd president and CEO. 'Through MDI, local entrepreneurs, individuals and businesses gain a competitive edge in the growing field of energy efficiency and can play a key role in advancing the clean energy transition.' MDI, launched in early 2024, integrates energy-efficiency skills training for both novice and experienced workers and entrepreneurs, while also providing opportunities for diverse vendors to obtain certifications and join a vendor database. This database will facilitate access to business opportunities through ComEd and other primary contractors. These resources aim to strengthen the current pipeline of diverse, skilled, and local talent necessary to undertake the increasing number of clean energy projects arising from the state's Climate and Equitable Jobs Act (CEJA). "The graduation of these Rockford-area residents from ComEd's Market Development Initiative represents a significant investment in our community's future," said Joseph Chiarelli, Chairman of the Winnebago County Board. "By providing our local workforce with specialized skills in energy efficiency, this program not only creates economic opportunities for our residents but also supports Winnebago County's commitment to sustainability and clean energy. We're proud to see our community members developing expertise that will benefit both their careers and our region's environmental goals." Since its inception over one year ago, ComEd's MDI program has successfully graduated a total of 80 participants across five distinct cohorts. Education and certification are offered to individuals from various experience levels and backgrounds, focusing on areas that support the energy efficiency industry, including: air sealing; mold identification and remediation; proper ventilation; and understanding how homes function as systems to improve energy efficiency. All training is provided at no cost to participants. Depending on the course, participants may be eligible for a weekly stipend, daily meals, and assistance with transportation. Additionally, ComEd's MDI enlists the support of over a dozen community-based organizations who serve as local navigators to recruit and connect job seekers and firms to training opportunities provided through the initiative. The skills and tools provided by MDI assist families and businesses throughout northern Illinois in leveraging the benefits of ComEd's award-winning Energy Efficiency Program, which includes services, rebates, and discounts to help customers manage energy usage and reduce bills. Since its start in 2008, the program has supported hundreds of thousands of families and businesses in saving a total of over $11 billion on energy bills and over 99 million megawatt-hours of electricity. Additionally, the program has contributed to reducing over 74 billion pounds of carbon emissions, equivalent to planting more than 33 million acres of trees. For an in-depth look into MDI and how individuals, businesses and entrepreneurs can apply and contribute to expanding the energy landscape, visit
Yahoo
21-05-2025
- Business
- Yahoo
ComEd Celebrates Rockford's First Graduating Class of New Market Development Initiative
5-week, hands-on training program provides northern Illinois residents with skills to complete in Illinois' fast-growing energy-efficiency sector ROCKFORD, Ill., May 21, 2025--(BUSINESS WIRE)--ComEd today graduated nearly a dozen participants of its first Skilled Cohort in Rockford; part of its Market Development Initiative (MDI) that provides resources and training to help create a diverse, local workforce that is qualified to take on roles in the growing energy efficiency industry. Over the course of five weeks, entrepreneurs completed training to become certified in the latest building standards and receive relevant knowledge to help advance their careers in energy efficiency, HVAC, or weatherization. "To help support the communities we're privileged to serve, ComEd has made increasing training and contracting opportunities a top priority," said Gil Quiniones, ComEd president and CEO. "Through MDI, local entrepreneurs, individuals and businesses gain a competitive edge in the growing field of energy efficiency and can play a key role in advancing the clean energy transition." MDI, launched in early 2024, integrates energy-efficiency skills training for both novice and experienced workers and entrepreneurs, while also providing opportunities for diverse vendors to obtain certifications and join a vendor database. This database will facilitate access to business opportunities through ComEd and other primary contractors. These resources aim to strengthen the current pipeline of diverse, skilled, and local talent necessary to undertake the increasing number of clean energy projects arising from the state's Climate and Equitable Jobs Act (CEJA). "The graduation of these Rockford-area residents from ComEd's Market Development Initiative represents a significant investment in our community's future," said Joseph Chiarelli, Chairman of the Winnebago County Board. "By providing our local workforce with specialized skills in energy efficiency, this program not only creates economic opportunities for our residents but also supports Winnebago County's commitment to sustainability and clean energy. We're proud to see our community members developing expertise that will benefit both their careers and our region's environmental goals." Since its inception over one year ago, ComEd's MDI program has successfully graduated a total of 80 participants across five distinct cohorts. Education and certification are offered to individuals from various experience levels and backgrounds, focusing on areas that support the energy efficiency industry, including: air sealing; mold identification and remediation; proper ventilation; and understanding how homes function as systems to improve energy efficiency. All training is provided at no cost to participants. Depending on the course, participants may be eligible for a weekly stipend, daily meals, and assistance with transportation. Additionally, ComEd's MDI enlists the support of over a dozen community-based organizations who serve as local navigators to recruit and connect job seekers and firms to training opportunities provided through the initiative. The skills and tools provided by MDI assist families and businesses throughout northern Illinois in leveraging the benefits of ComEd's award-winning Energy Efficiency Program, which includes services, rebates, and discounts to help customers manage energy usage and reduce bills. Since its start in 2008, the program has supported hundreds of thousands of families and businesses in saving a total of over $11 billion on energy bills and over 99 million megawatt-hours of electricity. Additionally, the program has contributed to reducing over 74 billion pounds of carbon emissions, equivalent to planting more than 33 million acres of trees. For an in-depth look into MDI and how individuals, businesses and entrepreneurs can apply and contribute to expanding the energy landscape, visit ComEd is a unit of Chicago-based Exelon Corporation (NASDAQ: EXC), a Fortune 250 energy company serving more than 10.5 million electricity and natural gas customers – the largest number of customers in the U.S. ComEd powers the lives of more than 4 million customers across northern Illinois, or 70 percent of the state's population. For more information visit and connect with the company on Facebook, Instagram, LinkedIn, X, and YouTube. View source version on Contacts ComEd Media Relations312-394-3500 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Cision Canada
21-05-2025
- Business
- Cision Canada
Medtronic announces intent to separate Diabetes business
Enables intense focus on highest margin growth drivers where Medtronic has leading core competencies GALWAY, Ireland, May 21, 2025 /CNW/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced its intent to separate its Diabetes business into a new standalone company ("New Diabetes Company"). This strategic decision for both Medtronic and New Diabetes Company will create a more focused Medtronic, with a more simplified portfolio in high margin growth markets. At the same time, it will create an independent, scaled leader in Diabetes, focused on accelerating innovation and differentiated as the only company to commercialize a complete ecosystem to address intensive insulin management. The separation is expected to be completed within 18 months through a series of capital markets transactions, with a preferred path of an initial public offering (IPO) and subsequent split-off. The separation is expected to unlock value for Medtronic and its shareholders, as it creates a New Diabetes Company shareholder base more aligned with its financial profile and is expected to be accretive to Medtronic gross margin, operating margin, and earnings per share (EPS). Medtronic Medtronic, a global leader in MedTech, has leading franchises in attractive MedTech markets and following this separation, it will become even more focused on innovation-driven growth and category leadership for healthcare systems and physician customers. Medtronic is taking action with decisive ongoing portfolio management and capital allocation to shift more focus to its highest profitable growth drivers tied to its core strengths. The company is building momentum with its growth drivers, advancing its innovation pipeline and "in the moment" product launches, including pulsed field ablation, renal denervation, implantable tibial neuromodulation, and soft tissue robotics. Following the separation, Medtronic will have enhanced benefit from its scale and strategic commercial, manufacturing, and technology synergies. Combined, these are expected to drive durable, mid-single digit or higher organic revenue growth and accelerate earnings leverage. New Diabetes Company New Diabetes Company will be a leading, scaled direct-to-consumer Diabetes business—uniquely positioned as the only company to commercialize a complete intensive insulin management ecosystem—giving people the freedom to forget diabetes and live their best lives. This separation is expected to enable more focused investment into New Diabetes Company's pipeline, as well as manufacturing scale and automation, positioning the company for success in Automated Insulin Delivery and Smart MDI, while driving margin expansion over time. The independent New Diabetes Company will have a shareholder base aligned with its business and financial profile. The Diabetes business is currently a team of more than 8,000 employees worldwide, with a global commercial footprint and dedicated innovation, manufacturing, clinical, and quality systems. Que Dallara, current EVP and president of Medtronic Diabetes, will become CEO of New Diabetes Company. "This marks a significant milestone in driving both Medtronic and the Diabetes business to achieve lasting value for Medtronic, our shareholders, customers, and patients," said Geoff Martha, chairman and CEO of Medtronic. "Active portfolio management is an important lever to delivering on our ongoing growth and success, and this decision shifts the Medtronic portfolio to have intense focus on our highest margin growth drivers where we have our strongest core competencies. I'm also excited about what the future holds for the Diabetes business. Que's impressive track record in driving growth and innovation has set Diabetes on a path to continued success, ensuring the needs of individuals with diabetes are met around the globe." "I'm incredibly grateful to Geoff for his vision and commitment to investing in the Diabetes business — we wouldn't be where we are without his unwavering support," said Dallara. "As we embark on this exciting new chapter, we celebrate the tireless efforts and dedication of our teams. Their passion and perseverance have brought us to this pivotal moment. Together, we're poised to transform lives, giving people the freedom to forget diabetes and live their best lives." Financial Details The Diabetes business represented 8% of Medtronic revenue and 4% of Medtronic segment operating profit in fiscal year 2025. Upon completion, the separation is expected to improve Medtronic adjusted gross margin by approximately 50 basis points, adjusted operating margins by approximately 100 basis points, and be immediately accretive to adjusted EPS. The separation is expected to provide the ability to retire Medtronic shares outstanding without reducing cash, resulting in EPS accretion and a reduction in the dividend liability for Medtronic, enabling increased growth-accretive investment. Medtronic expects its dividend per share to remain unchanged pre- and post-transaction with no change to its dividend policy. Transaction Details The capital markets separation will create an independent, publicly traded company. The company's preferred path for the separation is an IPO of New Diabetes Company, with a subsequent split-off transaction. This is expected to appropriately capitalize New Diabetes Company and provide the ability to retire shares in Medtronic. The separation is generally expected to be tax-free to Medtronic shareholders for U.S. federal income tax purposes. The separation will include the Diabetes business employees, product portfolio, pipeline, intellectual property, strategic partnerships, and global manufacturing facilities. Medtronic is targeting completion of the planned separation within 18 months, subject to customary conditions, including favorable market conditions, consultations with works councils and other employee representative bodies, final approval from the Medtronic Board of Directors, receipt of a favorable opinion with respect to the tax-free nature of the transaction for U.S. federal income tax purposes, and receipt of applicable regulatory approvals. Goldman Sachs & Co. LLC and BofA Securities, Inc. are acting as financial advisors to Medtronic in its review of strategic alternatives for the New Diabetes Company. Cleary Gottlieb Steen & Hamilton LLP and Baker McKenzie are acting as legal counsel, and Skadden, Arps, Slate, Meagher & Flom LLP is acting as special tax counsel, to Medtronic, and Davis Polk & Wardwell LLP is acting as legal counsel to the financial advisors. Presentation A presentation containing details on the proposed separation can be viewed by clicking on the Quarterly Earnings link at To view a PDF of the separation presentation, click here. Video Webcast Information Medtronic will host a video webcast today, May 21, at 8:00 a.m. EDT (7:00 a.m. CDT) to discuss this planned separation together with its fourth quarter and fiscal year 2025 financial results. This webcast can be accessed by clicking on the Quarterly Earnings icon at Within 24 hours of the webcast, a replay of the webcast and transcript of the company's prepared remarks will be available by clicking on the Past Events and Presentations link under the News & Events drop-down at About Medtronic Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic (NYSE: MDT), visit and follow on LinkedIn. Cautions Regarding Forward Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are subject to risks and uncertainties, including risks related to Medtronic's ability to satisfy the necessary conditions to consummate the separation of its Diabetes business on a timely basis or at all, Medtronic's ability to successfully separate its Diabetes business and realize the anticipated benefits from the separation (including consummating the transaction on a basis that is generally tax-free to shareholders), New Diabetes Company's ability to succeed as a standalone publicly traded company, competitive factors, difficulties and delays inherent in the development, manufacturing, marketing and sale of medical products, government regulation, geopolitical conflicts, changing global trade policies, general economic conditions, and other risks and uncertainties described in the company's periodic reports on file with the U.S. Securities and Exchange Commission including the most recent Annual Report on Form 10-K of the company. In some cases, you can identify these statements by forward-looking words or expressions, such as "anticipate," "believe," "could," "estimate," "expect," "forecast," "intend," "looking ahead," "may," "plan," "possible," "potential," "project," "should," "going to," "will," and similar words or expressions, the negative or plural of such words or expressions and other comparable terminology. Actual results may differ materially from anticipated results. Medtronic does not undertake to update its forward-looking statements or any of the information contained in this press release, including to reflect future events or circumstances. While a split-off is the company's current preferred separation structure, a final decision has not been reached at this time. The separation is expected to occur through a series of capital markets transactions, which may include a spin-off, split-off, offering, or combination thereof, of the company's remaining shareholding in New Diabetes Company. Contacts Erika Winkels Public Relations +1-763-526-8478 Ryan Weispfenning Investor Relations +1-763-505-4626 SOURCE Medtronic plc
Yahoo
14-05-2025
- Business
- Yahoo
Black Swan Graphene Announces Preferred Compounder Agreement with Modern Dispersions
Toronto, Ontario--(Newsfile Corp. - May 14, 2025) - Black Swan Graphene Inc. (TSXV: SWAN) (OTCQX: BSWGF) (FSE: R960) ("Black Swan" or the "Company") is pleased to announce the execution of a preferred compounder agreement with Modern Dispersions Inc. ("MDI"), a leading manufacturer of thermoplastic compounds and concentrates. This strategic partnership aims to promote MDI as a manufacturer of Graphene Enhanced Masterbatch™ ("GEM") for graphene applications, with Black Swan serving as a preferred supplier of Graphene Nanoplatelets ("GNP"). This agreement underscores Black Swan's commitment to fostering strategic partnerships that drive innovation and expand the applications of graphene across diverse industries. Key Highlights of the Agreement: Manufacturing Collaboration: MDI will manufacture GEM products utilizing Black Swan's GNP, leveraging MDI's extensive experience in masterbatch production to deliver high-quality, graphene-enhanced materials to the market. Global Promotion: Both companies will employ their respective commercial teams and partnerships to promote the benefits of GEM products across various regions, aiming to expand the global footprint of graphene-enhanced materials. Preferred Supplier Status: Black Swan is designated as a preferred supplier of GNP for MDI's GEM products, ensuring a consistent and reliable source of high-quality graphene materials. Technical Focus and Application Development The companies are actively exploring graphene integration into various polymer systems including polyethylene (PE), polypropylene (PP), thermoplastic polyurethane (TPU), and nylon, with the objective of delivering functional, scalable masterbatch solutions. The GEM platform developed with MDI provides several benefits to processors and end-users, including: Eliminates the need to handle dry nanomaterials; Enables more consistent and efficient dispersion; and Simplifies let-down ratios and extruder feeding during customer processing. To learn more about GEM masterbatch solutions, please visit the GEM section of Black Swan's website: Simon Marcotte, President and CEO of Black Swan, commented: "We are excited to formalize our partnership with Modern Dispersions. This collaboration represents a significant step forward in our mission to deliver high-performance graphene-enhanced materials to various industries. By combining MDI's manufacturing expertise with our advanced graphene technologies, we are well-positioned to address the evolving needs of the market." Marton A. Kozma, President of MDI, added: "Partnering with Black Swan allows us to integrate cutting-edge graphene materials into our product offerings. We look forward to working together to develop and promote innovative solutions that meet the high-performance demands of our customers." About Modern Dispersions Inc. Modern Dispersions Inc. is a leading manufacturer of black masterbatch, conductive compounds, and other thermoplastic concentrates in North America, specializing in engineered compounds that enhance the performance of plastics in various applications. With over a half of a century of experience, MDI offers high-quality materials tailored to customers' unique requirements through its extensive sales network. More information is available at: About Black Swan Graphene Inc. Black Swan is focused on the large-scale production and commercialization of patented high-performance and low-cost graphene products aimed at several volume driven industrial sectors, including concrete, polymers, and others. Black Swan's graphene processing technology was developed by Thomas Swan & Co. Ltd. ("Thomas Swan") over the last decade. Thomas Swan is a United Kingdom-based global chemicals manufacturer with a century-long track record and a reputation for being at the forefront of advanced materials and graphene innovation. Since 2024, Black Swan has launched seven commercially available Graphene Enhanced MasterbatchTM (GEM) polymer products which are currently being tested by several international clients. More information is available at: For more information please contact: Paul Hardy, Vice President - Corporate Developmentphardy@ (416) 844-7365 Black Swan Graphene Inc. on behalf of the Board of Directors Simon Marcotte, CFA, President & Chief Executive Officer Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Forward-Looking Statements This news release contains forward-looking statements and forward-looking information (collectively, "forward-looking statements") within the meaning of applicable Canadian legislation. Forward-looking statements are typically identified by words such as: "believes", "expects", "anticipates", "intends", "estimates", "plans", "may", "should", "would", "will", "potential", "scheduled" or variations of such words and phrases and similar expressions, which, by their nature, refer to future events or results that may, could, would, might or will occur or be taken or achieved. All statements in this news release that are not purely historical are forward-looking statements and include statements regarding beliefs, plans, expectations and orientations regarding the future including, without limitation: statements with respect to the expectations of management regarding the Offering; the expectations of management regarding the use of proceeds of the Offering; and the closing of the Offering. Although the Company believes that such statements are reasonable and reflect expectations of future developments and other factors which management believes to be reasonable and relevant, the Company can give no assurance that such expectations will prove to be correct. In making the forward-looking statements in this news release, the Company has applied several material assumptions, including without limitation, that market fundamentals will support the business of the Company as well as in relation to the Offering and Closing thereof. Other factors may also adversely affect the future results or performance of the Company, including general economic, market or business conditions, changes in the financial markets and in the demand for graphene and graphene products, changes in laws, regulations and policies affecting the graphene industry. The ongoing labour shortages, inflationary pressures, fluctuations in interest rates, the global financial climate and geopolitical conflicts in various regions, including Ukraine and the Middle East, are some additional factors that are affecting current economic conditions and increasing economic uncertainty, which may impact the Company's operating performance, financial position, and future prospects. Collectively, the potential impacts of this economic environment pose risks that are currently indescribable and immeasurable. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned that forward-looking statements are not guarantees of future performance or events and, accordingly, are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty of such statements. The Company does not undertake any obligation to update such forward‐looking information whether because of new information, future events or otherwise, except as expressly required by applicable law. To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
